© 2016 Elsevier Inc. Multi-locus sequence typing was used to reveal a high degree of diversity amongst the E. coli isolates with AmpC plasmid genes, and a high prevalence of the −32 mutation present
Two mechanisms account for AmpC activity in Escherichia coli, namely, mutations in the ampC promoter...
This study determined the prevalence and distribution of plasmid-mediated AmpC (pAmpC) b-lactamases ...
The aim of the study was to investigate the molecular epidemiology of 87 third-generation cephalospo...
© 2016 Elsevier Inc. Multi-locus sequence typing was used to reveal a high degree of diversity among...
AmpC β-lactamase is an enzyme commonly produced by Escherichia coli that causes resistance to cephal...
OBJECTIVE: To characterize the genetic determinants associated with an AmpC phenotype in clinical Es...
Escherichia coli is a common human pathogen, capable of causing a wide range of infections. Some str...
Objectives: To characterize the AmpC-type b-lactamases produced by Escherichia coli clinical isolate...
The ampC promoter and attenuator regions of an Escherichia coli clinical isolate from a public hospi...
Cephalosporins resistance is increasing in Escherichia coli in Spain. We characterize infections by ...
Cephalosporins resistance is increasing in Escherichia coli in Spain. We characterize infections by ...
Objectives: To determine the phylogenetic group and the production of different virulence factors (V...
Objectives: To characterize the -lactamase genes of the expanded-spectrum cephalosporin-resistant Es...
AmpC β-lactamases hydrolyze all β-lactams except cefepime and carbapenems. The study of AmpC-produci...
Objectives The aim of the study was to examine resistance mechanisms associated with an AmpC phenoty...
Two mechanisms account for AmpC activity in Escherichia coli, namely, mutations in the ampC promoter...
This study determined the prevalence and distribution of plasmid-mediated AmpC (pAmpC) b-lactamases ...
The aim of the study was to investigate the molecular epidemiology of 87 third-generation cephalospo...
© 2016 Elsevier Inc. Multi-locus sequence typing was used to reveal a high degree of diversity among...
AmpC β-lactamase is an enzyme commonly produced by Escherichia coli that causes resistance to cephal...
OBJECTIVE: To characterize the genetic determinants associated with an AmpC phenotype in clinical Es...
Escherichia coli is a common human pathogen, capable of causing a wide range of infections. Some str...
Objectives: To characterize the AmpC-type b-lactamases produced by Escherichia coli clinical isolate...
The ampC promoter and attenuator regions of an Escherichia coli clinical isolate from a public hospi...
Cephalosporins resistance is increasing in Escherichia coli in Spain. We characterize infections by ...
Cephalosporins resistance is increasing in Escherichia coli in Spain. We characterize infections by ...
Objectives: To determine the phylogenetic group and the production of different virulence factors (V...
Objectives: To characterize the -lactamase genes of the expanded-spectrum cephalosporin-resistant Es...
AmpC β-lactamases hydrolyze all β-lactams except cefepime and carbapenems. The study of AmpC-produci...
Objectives The aim of the study was to examine resistance mechanisms associated with an AmpC phenoty...
Two mechanisms account for AmpC activity in Escherichia coli, namely, mutations in the ampC promoter...
This study determined the prevalence and distribution of plasmid-mediated AmpC (pAmpC) b-lactamases ...
The aim of the study was to investigate the molecular epidemiology of 87 third-generation cephalospo...